Reed Jobs Says AI and Patent Cliffs Are Accelerating Yosemite's Cancer Research Push
Reed Jobs, son of Apple co-founder Steve Jobs, sat down with TechCrunch to discuss the rapid growth of his biotech venture firm Yosemite. Since its debut nearly three years ago, the firm has expanded to a team of 17 and sharpened its focus on cancer research. A wave of blockbuster drugs losing patent protection around the same period is opening new investment opportunities in the biotech space. Jobs also noted that artificial intelligence has evolved from a peripheral interest into a core part of how Yosemite operates. He admitted the firm's pace of growth has exceeded his own expectations.
This is an AI-generated summary. ShortSingh links to the original source for the complete article.


Discussion (0)
Log in to join the discussion and vote.
Log in